200
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Optimizing Intrapleural Bevacizumab Dosing in Non-Small-Cell Lung Cancer-Mediated Malignant Pleural Effusion: Less is More

, , , , &
Pages 2131-2138 | Received 30 Jan 2018, Accepted 28 Feb 2018, Published online: 16 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wu Di, Cong Yue, Zhang Ziran, Zhang Jie, Nie Jun, Dai Ling, Hu Weiheng, Chen Xiaoling, Ma Xiangjuan, Tian Guangming, Han Jindi, Han Sen, Wang Yang, Long Jieran & Fang Jian. (2022) A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion. Future Oncology 18:6, pages 669-677.
Read now

Articles from other publishers (3)

Baocheng Wang, Chen Zhong, Zijun Liao, Haitao Wang, Xiuyu Cai, Yanbing Zhang, Jun Wang, Tianxiao Wang & Hongtao Yao. (2023) Effectiveness and safety of human type 5 recombinant adenovirus ( H101 ) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real‐world study . Thoracic Cancer 14:30, pages 3051-3057.
Crossref
Yuhua Zhao, Limeng Yu, Lili Wang, Yingxi Wu, Haiyang Chen, Qiming Wang & Yufeng Wu. (2023) Current status of and progress in the treatment of malignant pleural effusion of lung cancer. Frontiers in Oncology 12.
Crossref
Keke Nie, Zhen Zhang, Yunhong You, Xingjun Zhuang, Chunling Zhang & Youxin Ji. (2019) A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer. Thoracic Cancer 11:1, pages 8-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.